Tamarack Advisers, LP - Q3 2021 holdings

$317 Million is the total value of Tamarack Advisers, LP's 45 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 78.4% .

 Value Shares↓ Weighting
HSIC BuyHENRY SCHEIN INCequity$30,464,000
+30.4%
400,000
+27.0%
9.62%
+45.3%
RIGL BuyRIGEL PHARMACEUTICALS INCequity$25,410,000
-8.5%
7,000,000
+9.4%
8.02%
+2.0%
MDT SellMEDTRONIC PLCequity$25,070,000
-19.2%
200,000
-20.0%
7.92%
-9.9%
PCRX BuyPACIRA BIOSCIENCES INCequity$21,000,000
-3.9%
375,000
+4.2%
6.63%
+7.2%
PDCO BuyPATTERSON COS INCequity$14,919,000
+3.4%
495,000
+4.2%
4.71%
+15.2%
TPB SellTURNING POINT BRANDS INCequity$13,131,000
-28.3%
275,000
-31.2%
4.15%
-20.1%
ELY BuyCALLAWAY GOLF COMPANYequity$12,434,000
+123.4%
450,000
+172.7%
3.93%
+149.1%
UTHR BuyUNITED THERAPEUTICS CORPequity$11,998,000
+7.9%
65,000
+4.8%
3.79%
+20.2%
PRGO BuyPERRIGO CO PLCequity$11,833,000
+416.0%
250,000
+400.0%
3.74%
+474.8%
VRAY SellVIEWRAY INCequity$11,536,000
-12.6%
1,600,000
-20.0%
3.64%
-2.6%
ITGR SellINTEGER HOLDINGS CORPequity$11,168,000
-12.2%
125,000
-7.4%
3.53%
-2.1%
MSON BuyMISONIX INCequity$10,120,000
+21.7%
400,000
+6.7%
3.20%
+35.6%
LNTH SellLANTHEUS HOLDINGS INCequity$10,015,000
-19.5%
390,000
-13.3%
3.16%
-10.2%
ANGO BuyANGIODYNAMICS INCequity$9,079,000
+11.5%
350,000
+16.7%
2.87%
+24.4%
STRM  STREAMLINE HEALTH SOLUTIONSequity$8,629,000
-1.1%
4,930,8820.0%2.72%
+10.2%
SIBN BuySI-BONE INCequity$8,568,000
+6.8%
400,000
+56.9%
2.70%
+19.0%
ICUI BuyICU MEDICAL INCequity$8,168,000
+16.7%
35,000
+2.9%
2.58%
+30.1%
ATRC SellATRICURE INCequity$8,137,000
-31.6%
117,000
-22.0%
2.57%
-23.8%
MDRX BuyALLSCRIPTS HEALTHCARE SOLUTIequity$7,688,000
-7.7%
575,000
+27.8%
2.43%
+2.9%
STE NewSTERIS PLCequity$7,354,00036,000
+100.0%
2.32%
BVS BuyBIOVENTUS INC - Aequity$6,797,000
-18.7%
480,000
+1.1%
2.15%
-9.4%
RDNT SellRADNET INCequity$5,569,000
-26.5%
190,000
-15.6%
1.76%
-18.1%
THC NewTENET HEALTHCARE CORPequity$4,983,00075,000
+100.0%
1.57%
PHR SellPHREESIA INCequity$4,628,000
-32.5%
75,000
-32.9%
1.46%
-24.7%
AHCO SellADAPTHEALTH CORPequity$4,076,000
-50.4%
175,000
-41.7%
1.29%
-44.7%
ISEE SellIVERIC BIO INCequity$4,060,000
+60.9%
250,000
-37.5%
1.28%
+79.3%
PLXS BuyPLEXUS CORPequity$3,576,000
+179.4%
40,000
+185.7%
1.13%
+211.0%
TALK NewTALKSPACE INCequity$2,920,000800,000
+100.0%
0.92%
SellDERMTECH INCequity$2,729,000
-51.4%
85,000
-37.0%
0.86%
-45.8%
SPY NewSPY US 10/01/21 P440put$2,060,0002,000
+100.0%
0.65%
NVST NewENVISTA HOLDINGS CORPequity$1,881,00045,000
+100.0%
0.59%
NewSOMALOGIC INCequity$1,859,000150,000
+100.0%
0.59%
NewTERRASCEND CORPequity$1,760,000250,000
+100.0%
0.56%
ARKG NewARKG US 10/15/21 P85put$735,000750
+100.0%
0.23%
CERS  CERUS CORPequity$457,000
+3.2%
75,0000.0%0.14%
+15.2%
HOLX NewHOLX US 12/17/21 C75call$420,0001,000
+100.0%
0.13%
HSIC NewHSIC US 11/19/21 C80call$405,0001,500
+100.0%
0.13%
GTBIF NewGREEN THUMB INDUSTRIES INCequity$278,00010,000
+100.0%
0.09%
VTRS NewVTRS US 01/21/22 C15call$250,0005,000
+100.0%
0.08%
PFE NewPFE US 11/19/21 C43call$156,0001,000
+100.0%
0.05%
NUVA NewNUVA US 11/19/21 P65put$143,000231
+100.0%
0.04%
RIGL NewRIGL US 01/21/22 C10call$100,0005,000
+100.0%
0.03%
NewSomalogic Inc Warrantwarrant$69,00020,000
+100.0%
0.02%
MSACW  MEDICUS SCIENCES ACQ -CW27warrant$47,000
-29.9%
66,6650.0%0.02%
-21.1%
BMRN NewBMRN US 10/15/21 C85call$23,0001,500
+100.0%
0.01%
ExitXLV US 07/16/21 P120put$0-1,500
-100.0%
-0.01%
ExitGLD US 09/17/21 C200call$0-5,000
-100.0%
-0.02%
ExitPFE US 07/16/21 C40call$0-3,500
-100.0%
-0.02%
ExitCTVA US 07/16/21 C44call$0-1,500
-100.0%
-0.04%
ExitARKG US 07/16/21 P90put$0-1,500
-100.0%
-0.06%
ExitBMY US 09/17/21 C70call$0-2,500
-100.0%
-0.07%
ExitBSX US 07/16/21 C42call$0-2,000
-100.0%
-0.07%
LH ExitLABORATORY CRP OF AMER HLDGSequity$0-1,000
-100.0%
-0.08%
ExitSPY US 07/16/21 P420put$0-3,500
-100.0%
-0.09%
ExitHOLX US 12/17/21 C75call$0-2,500
-100.0%
-0.16%
BIO ExitBIO-RAD LABORATORIES-Aequity$0-1,000
-100.0%
-0.18%
ExitABT US 08/20/21 P120put$0-1,000
-100.0%
-0.19%
CMIIU ExitCM LIFE SCIENCES II INCequity unit$0-50,000
-100.0%
-0.19%
AYRWF ExitAYR WELLNESS INCequity$0-31,500
-100.0%
-0.25%
ExitIWM US 08/20/21 P220put$0-5,000
-100.0%
-0.45%
DGX ExitQUEST DIAGNOSTICS INCequity$0-15,000
-100.0%
-0.56%
CNC ExitCENTENE CORPequity$0-35,000
-100.0%
-0.72%
MSACU ExitMEDICUS SCIENCES ACQUISITI-Aequity$0-296,636
-100.0%
-0.81%
INNV ExitINNOVAGE HOLDING CORPequity$0-141,000
-100.0%
-0.85%
CI ExitCIGNA CORPequity$0-35,000
-100.0%
-2.35%
CVS ExitCVS HEALTH CORPequity$0-100,000
-100.0%
-2.36%
VTRS ExitVIATRIS INCequity$0-825,000
-100.0%
-3.34%
UNH ExitUNITEDHEALTH GROUP INCequity$0-30,000
-100.0%
-3.40%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERADIGM ORD32Q3 202313.9%
STREAMLINE HEALTH SOLUTIONS ORD30Q3 20234.0%
ATRICURE ORD29Q3 20237.6%
PACIRA PHARMACEUTICALS INC27Q1 202312.1%
LANTHEUS HOLDINGS ORD25Q4 20229.6%
MEDTRONIC PLC21Q1 202212.7%
RIGEL PHARMACEUTICALS ORD21Q2 20238.0%
BIO RAD LABORATORIES CL A ORD19Q2 202310.0%
HOLOGIC INC17Q1 20226.5%
SPY US 10/21/16 P21017Q3 202341.5%

View Tamarack Advisers, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Tamarack Advisers, LP Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
STREAMLINE HEALTH SOLUTIONS INC.June 22, 20235,514,5159.4%
IVERIC bio, Inc.February 16, 2021850,0000.1%
Correvio Pharma Corp.February 14, 20202,500,0004.9%
OBALON THERAPEUTICS INCFebruary 14, 2020? ?
Correvio Pharma Corp.February 15, 2019? ?
Corium International, Inc.February 15, 2017737,2423.3%
ENDOLOGIX INC /DE/Sold outFebruary 15, 201700.0%
Imprivata IncSold outFebruary 15, 201700.0%

View Tamarack Advisers, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-16
13F-HR2023-08-10
SC 13D/A2023-06-22
13F-HR2023-05-11
13F-HR2023-02-13
SC 13D/A2022-12-01
13F-HR2022-11-15
13F-HR2022-08-16
13F-HR2022-05-11

View Tamarack Advisers, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (316701000.0 != 316702000.0)

Export Tamarack Advisers, LP's holdings